Editorial comment on “Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain”
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.13980 ↗Kurz gefasst
Editorial in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Ayobami Akenroye und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Brigham & Women's Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, US…. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents, Hypersensitivity. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Clinical Immunology, Brigham & Women's Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
- Channing Division of Network Medicine, Brigham & Women's Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Ayobami Akenroye
Zitieren
APA
Akenroye, A., & Phipatanakul, W. (2023). Editorial comment on “Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain”. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13980
Vancouver
Akenroye A, Phipatanakul W. Editorial comment on “Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain”. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.13980
BibTeX
@article{Akenroye2023,
author = {Akenroye, Ayobami and Phipatanakul, Wanda},
title = {Editorial comment on “Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain”},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.13980}
}
EUVIMED